Targeting HIF2α Translation with Tempol in VHL-Deficient Clear Cell Renal Cell Carcinoma
Carole Sourbier(Center for Drug Evaluation and Research), W. Marston Linehan(National Cancer Institute)
Cited by 21
Related Papers
Metabolic Reprogramming for Producing Energy and Reducing Power in Fumarate Hydratase Null Cells from Hereditary Leiomyomatosis Renal Cell Carcinoma
|PLoS ONE|2013|110
Targeting loss of the Hippo signaling pathway in <i>NF2</i>-deficient papillary kidney cancers
|Oncotarget|2018|57
Mitochondrial DNA mutations distinguish bilateral multifocal renal oncocytomas from familial Birt–Hogg–Dubé tumors
|Modern Pathology|2015|30
High-throughput and targeted drug screens identify pharmacological candidates against MiT-translocation renal cell carcinoma
|Journal of Experimental & Clinical Cancer Research|2023|18